IVDR Technical Documentation2025-09-12T03:26:25+05:30
IVDR Technical Documentation

our approach aimed at maximizing productivity & efficiency.

IVDR Technical Documentation

Under the new EU In Vitro Diagnostic Regulation (IVDR 2017/746), every IVD device placed on the EU market must have complete Technical Documentation (TD). This is required because:

  1. Demonstrates Compliance: It proves that the device meets General Safety and Performance Requirements (GSPR) outlined in IVDR Annex I.

  2. Notified Body Review and Approval: Without TD, the manufacturer cannot obtain or maintain CE Certification.

  3. Ensures Transparency & Traceability: Authorities, Notified Bodies, and Competent Authorities can review it during conformity assessments, audits, or inspections.

  4. Patient Safety & Performance: IVDR Technical Documentation includes risk management, performance evaluation, and analytical data to confirm that the device is safe and performs as intended.

  5. Regulatory Obligation: Article 10(4) of IVDR makes technical documentation mandatory for all manufacturers (whether self-certified or via a Notified Body).

Role of Consultants in IVDR Technical Documentation

Preparing IVDR Technical Documentation is complex, especially with stricter requirements compared to IVDD. Consultants help by:

  • Gap Assessment

    Reviewing existing files (IVDD-era files) and identifying missing elements needed for IVDR compliance.

  • Structuring the Documentation

    Organizing files per IVDR Annex II & III requirements (Device description, design & manufacturing, GSPR checklist, performance evaluation, PMS/PMCF plans, risk management, etc.).

  • Performance Evaluation

    Supporting in literature search, clinical data appraisal, and preparation of Performance Evaluation Report (PER).

  • Liaising with Notified Bodies

    Preparing documentation in the exact format expected, handling questions, and responding to review comments.

  • Reducing Regulatory Risk

    Ensuring that the documentation is audit-ready, avoiding costly delays or rejections

  • Training & Process Setup

    Helping manufacturers build internal capability for Post-Market Surveillance (PMS) and Periodic Safety Update Reports (PSUR) under IVDR.

Overall IVDR CE Marking Process

  1. Classify device (A, B, C, D).

  2. Implement ISO 13485 QMS.

  3. Prepare Technical Documentation & Performance Evaluation.

  4. Undergo Notified Body review + onsite audit.

  5. Obtain CE Certificate → Affix CE Mark → Maintain compliance via PMS.

service related FAQ’s

What is included in a Biological Evaluation Report (BER)?2025-08-04T12:33:26+05:30

A Biological Evaluation Report (BER) summarizes the device’s biological risk assessment, including device description, material characterization, exposure categorization, literature review, testing results (if applicable), and a toxicological risk assessment. It concludes whether the device is biologically safe and compliant with ISO 10993.

Is GMP compliance mandatory for medical device manufacturers?2025-08-06T04:26:10+05:30

Yes, GMP compliance is mandatory for medical device manufacturers who market products in the United States. The FDA enforces GMP through the Quality System Regulation (21 CFR Part 820), which outlines the minimum requirements for design, production, labeling, packaging, and storage of medical devices to ensure safety and effectiveness.

Which standards apply to Human Factors and Usability?2025-08-27T15:07:52+05:30

Key standards include:

  • ISO 62366-1 – Usability engineering for medical devices.

  • ISO 14971 – Risk management for medical devices.

  • IEC 60601-1-6 – Usability requirements for medical electrical equipment.

  • ISO 20916 – Performance studies for IVDs.

Is biocompatibility testing always required for biological evaluation?2025-08-04T12:32:38+05:30

Not always. If sufficient historical data or literature exists to demonstrate the safety of materials used in the device, some tests may be waived. A gap analysis helps determine whether existing data is adequate or if additional testing (e.g., cytotoxicity, irritation, sensitization) is required to meet regulatory expectations.

Its highly recommended to conduct testing of finished salable device before you apply for regulatory clearance.

Labelling Requirements for Medical and In Vitro Diagnostic Devices for Clinical Use2025-08-16T05:58:13+05:30

Any medical device or new in vitro diagnostic medical device that is imported or manufactured for the purpose of clinical investigation, clinical performance evaluation, testing, evaluation, demonstration, or training must be kept in containers with labels clearly indicating:

  • Name of the product or code number

  • Batch or lot number

  • Serial number (wherever applicable)

  • Date of manufacture

  • Use-before date

  • Storage conditions

  • Name and address of the manufacturer

  • The specific purpose for which it has been manufactured

  • “For Clinical Investigation / Evaluation Only – Not for Sale”

get a free quote
Go to Top